Investing

Investment Purchases

Gilead Sciences Investment Purchases increased by 3650.0% to $525.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3181.3%, from $16.00M to $525.00M. Over 4 years (FY 2021 to FY 2025), Investment Purchases shows a downward trend with a -23.1% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2020
Last reportedQ4 2025

How to read this metric

An increase indicates a surplus of cash being deployed into financial markets rather than core operations; a decrease may suggest a need for liquidity.

Detailed definition

The total cash outflow for the acquisition of debt and equity securities, including marketable securities and other fina...

Peer comparison

Large-cap technology firms often show high outflows here as they manage massive cash reserves across global portfolios.

Metric ID: purchases_of_investments

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$22.00M$31.00M$48.00M$28.00M$16.00M$122.00M$6.00M$125.00M$67.00M$26.00M$224.00M$410.00M$34.00M$9.00M$39.00M$16.00M$2.00B-$1.90B$14.00M$525.00M
QoQ Change+40.9%+54.8%-41.7%-42.9%+662.5%-95.1%>999%-46.4%-61.2%+761.5%+83.0%-91.7%-73.5%+333.3%-59.0%>999%-194.8%+100.7%>999%
YoY Change-27.3%+293.5%-87.5%+346.4%+318.8%-78.7%>999%+228.0%-49.3%-65.4%-82.6%-96.1%>999%<-999%-64.1%>999%
Range-$1.90B$2.00B
CAGR+95.0%
Avg YoY Growth-496.6%
Median YoY Growth-38.3%
Current Streak2 quarters growth

Frequently Asked Questions

What is Gilead Sciences's investment purchases?
Gilead Sciences (GILD) reported investment purchases of $525.00M in Q1 2026.
How has Gilead Sciences's investment purchases changed year-over-year?
Gilead Sciences's investment purchases increased by 3181.3% year-over-year, from $16.00M to $525.00M.
What is the long-term trend for Gilead Sciences's investment purchases?
Over 4 years (2021 to 2025), Gilead Sciences's investment purchases has grown at a -23.1% compound annual growth rate (CAGR), from $380.00M to $133.00M.
What does investment purchases mean?
The amount of money a company spent to buy stocks, bonds, or other investment securities.